|
US6331658B1
(en)
*
|
1993-04-20 |
2001-12-18 |
Integris Baptist Medical Center, Inc. |
Genetically engineered mammals for use as organ donors
|
|
US5849991A
(en)
*
|
1994-01-27 |
1998-12-15 |
Bresatch Limited |
Mice homozygous for an inactivated α 1,3-galactosyl transferase gene
|
|
CA2196311A1
(en)
*
|
1994-08-19 |
1996-02-29 |
David H. Sachs |
Genetically engineered swine cells
|
|
US5913900A
(en)
*
|
1995-06-07 |
1999-06-22 |
Corsscart, Inc. |
Substantially native meniscal cartilage heterografts
|
|
US6046379A
(en)
*
|
1995-06-07 |
2000-04-04 |
Stone; Kevin R. |
Meniscal xenografts
|
|
US5865849A
(en)
*
|
1995-06-07 |
1999-02-02 |
Crosscart, Inc. |
Meniscal heterografts
|
|
US5984858A
(en)
*
|
1995-06-07 |
1999-11-16 |
Crosscart, Inc. |
Meniscal xenografts
|
|
US6231608B1
(en)
|
1995-06-07 |
2001-05-15 |
Crosscart, Inc. |
Aldehyde and glycosidase-treated soft and bone tissue xenografts
|
|
US5902338A
(en)
*
|
1995-09-15 |
1999-05-11 |
Crosscart, Inc. |
Anterior cruciate ligament heterograft
|
|
US6049025A
(en)
*
|
1995-09-15 |
2000-04-11 |
Stone; Kevin R. |
Articular cartilage xenografts
|
|
US6110206A
(en)
|
1995-09-15 |
2000-08-29 |
Crosscart, Inc. |
Anterior cruciate ligament xenografts
|
|
US5782915A
(en)
*
|
1995-09-15 |
1998-07-21 |
Stone; Kevin R. |
Articular cartilage heterografts
|
|
US6210440B1
(en)
|
1995-09-15 |
2001-04-03 |
Kevin R. Stone |
Anterior cruciate ligament xenografts
|
|
US5944755A
(en)
*
|
1995-09-15 |
1999-08-31 |
Crosscart, Inc. |
Articular cartilage xenografts
|
|
US6166288A
(en)
*
|
1995-09-27 |
2000-12-26 |
Nextran Inc. |
Method of producing transgenic animals for xenotransplantation expressing both an enzyme masking or reducing the level of the gal epitope and a complement inhibitor
|
|
WO1997016064A1
(en)
*
|
1995-11-03 |
1997-05-09 |
The Mount Sinai Medical Center |
Methods and compositions for the reduction of xenotransplantation rejection
|
|
US6235969B1
(en)
*
|
1997-01-10 |
2001-05-22 |
University Of Massachusetts |
Cloning pigs using donor nuclei from non-quiescent differentiated cells
|
|
US6011197A
(en)
|
1997-03-06 |
2000-01-04 |
Infigen, Inc. |
Method of cloning bovines using reprogrammed non-embryonic bovine cells
|
|
JP2002505144A
(ja)
|
1998-03-06 |
2002-02-19 |
クロスカート インコーポレイテッド |
軟組織異種移植片
|
|
US6383732B1
(en)
|
1999-02-11 |
2002-05-07 |
Crosscart, Inc. |
Method of preparing xenograft heart valves
|
|
US6972041B1
(en)
|
1998-03-16 |
2005-12-06 |
Crosscart, Inc. |
Bone xenografts
|
|
US6509187B2
(en)
*
|
1998-05-25 |
2003-01-21 |
Agrobiogen Gmbh |
Method and device for collection and preparation of tissue samples for molecular genetic diagnostics
|
|
JP2990268B1
(ja)
*
|
1998-08-31 |
1999-12-13 |
工業技術院長 |
機能性核酸転写用発現系
|
|
ATE236250T1
(de)
*
|
1998-09-25 |
2003-04-15 |
Deutsches Krebsforsch |
Antisense-sequenzen für die hemmung der expression des adhäsionsmoleküls icam-1
|
|
AU6218899A
(en)
*
|
1998-10-12 |
2000-05-01 |
Geron Bio-Med Limited |
Porcine oocytes with improved developmental competence
|
|
WO2000024912A1
(en)
*
|
1998-10-23 |
2000-05-04 |
The Children's Medical Center Corporation |
Use of a self-cleaving rna motif to modulate gene expression
|
|
US6258998B1
(en)
|
1998-11-24 |
2001-07-10 |
Infigen, Inc. |
Method of cloning porcine animals
|
|
US6700037B2
(en)
|
1998-11-24 |
2004-03-02 |
Infigen, Inc. |
Method of cloning porcine animals
|
|
US6267786B1
(en)
|
1999-02-11 |
2001-07-31 |
Crosscart, Inc. |
Proteoglycan-reduced soft tissue xenografts
|
|
US20020012660A1
(en)
*
|
1999-03-04 |
2002-01-31 |
Alan Colman |
Method of preparing a somatic cells for nuclear transfer
|
|
EP1220928A2
(en)
*
|
1999-09-30 |
2002-07-10 |
Alexion Pharmaceuticals, Inc. |
Compositions and methods for altering gene expression
|
|
AU1099701A
(en)
*
|
1999-10-22 |
2001-05-08 |
University Of Pittsburgh |
Alpha1-3 galactosyltransferase gene and promoter
|
|
US7820878B2
(en)
|
1999-11-19 |
2010-10-26 |
Kyowa Hakko Kirin Co., Ltd. |
Production of ungulates, preferably bovines that produce human immunoglobulins
|
|
US7074983B2
(en)
*
|
1999-11-19 |
2006-07-11 |
Kirin Beer Kabushiki Kaisha |
Transgenic bovine comprising human immunoglobulin loci and producing human immunoglobulin
|
|
US7414170B2
(en)
|
1999-11-19 |
2008-08-19 |
Kirin Beer Kabushiki Kaisha |
Transgenic bovines capable of human antibody production
|
|
WO2001035735A1
(en)
*
|
1999-11-19 |
2001-05-25 |
Hematech, Llc |
Production of ungulates, preferably bovines that produce human immunoglobulins
|
|
NZ525607A
(en)
|
2000-12-22 |
2005-05-27 |
Aurox Llc |
Methods for cloning mammals using reprogrammed donor chromatin or donor cells
|
|
US7491534B2
(en)
|
2000-12-22 |
2009-02-17 |
Kirin Holdings Kabushiki Kaisha |
Methods for altering cell fate to generate T-cells specific for an antigen of interest
|
|
US20020142397A1
(en)
*
|
2000-12-22 |
2002-10-03 |
Philippe Collas |
Methods for altering cell fate
|
|
EP1373498A2
(en)
*
|
2001-03-21 |
2004-01-02 |
Geron Corporation |
Animal tissue with carbohydrate antigens compatible for human transplantation
|
|
US7126039B2
(en)
|
2001-03-21 |
2006-10-24 |
Geron Corporation |
Animal tissue with carbohydrate antigens compatible for human transplantation
|
|
US20030153044A1
(en)
*
|
2001-05-14 |
2003-08-14 |
Monika Liljedahl |
Tissues or organs for use in xenotransplantation
|
|
US20030092174A1
(en)
*
|
2001-05-14 |
2003-05-15 |
Monika Liljedahl |
Tissues or organs for use in xenotransplantation
|
|
US6702744B2
(en)
|
2001-06-20 |
2004-03-09 |
Advanced Cardiovascular Systems, Inc. |
Agents that stimulate therapeutic angiogenesis and techniques and devices that enable their delivery
|
|
WO2003005810A2
(en)
*
|
2001-07-09 |
2003-01-23 |
Alexion Pharmaceuticals Inc. |
Cloned non-human mammals from contact inhibited donor cells
|
|
US8608661B1
(en)
|
2001-11-30 |
2013-12-17 |
Advanced Cardiovascular Systems, Inc. |
Method for intravascular delivery of a treatment agent beyond a blood vessel wall
|
|
JP2005514016A
(ja)
*
|
2001-12-21 |
2005-05-19 |
ザ キュレイターズ オブ ザ ユニバーシティ オブ ミズーリ |
ノックアウトブタ及びその製造方法
|
|
JP2003225089A
(ja)
*
|
2002-02-04 |
2003-08-12 |
National Institute Of Agrobiological Sciences |
ブタｒａｇ−１遺伝子およびその利用
|
|
US7361368B2
(en)
|
2002-06-28 |
2008-04-22 |
Advanced Cardiovascular Systems, Inc. |
Device and method for combining a treatment agent and a gel
|
|
WO2004016742A2
(en)
*
|
2002-08-14 |
2004-02-26 |
Immerge Biotherapeutics, Inc. |
α(1,3)-GALACTOSYLTRANSFERASE NULL CELLS, METHODS OF SELECTING AND α(1,3)-GALACTOSYLTRANSFERASE NULL SWINE PRODUCED THEREFROM
|
|
CA2899360A1
(en)
*
|
2002-08-21 |
2004-04-08 |
Revivicor, Inc. |
Porcine animals lacking any expression of functional alpha 1,3 galactosyltransferase
|
|
MXPA05004870A
(es)
*
|
2002-11-08 |
2005-11-04 |
Hematech Llc |
Ungulados transgenicos que tienen actividad reducida de la proteina prion y sus usos.
|
|
US8821473B2
(en)
|
2003-04-15 |
2014-09-02 |
Abbott Cardiovascular Systems Inc. |
Methods and compositions to treat myocardial conditions
|
|
US7641643B2
(en)
*
|
2003-04-15 |
2010-01-05 |
Abbott Cardiovascular Systems Inc. |
Methods and compositions to treat myocardial conditions
|
|
US8038991B1
(en)
|
2003-04-15 |
2011-10-18 |
Abbott Cardiovascular Systems Inc. |
High-viscosity hyaluronic acid compositions to treat myocardial conditions
|
|
EP1651050B1
(en)
|
2003-07-21 |
2012-08-22 |
Lifecell Corporation |
Acellular tissue matrices made from galactose alpha-1,3-galactose -deficient tissue
|
|
EP1685148A2
(en)
|
2003-11-05 |
2006-08-02 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
PORCINE ISOGLOBOSIDE 3 SYNTHASE PROTEIN, cDNA, GENOMIC ORGANIZATION, AND REGULATORY REGION
|
|
EP1734814B1
(en)
|
2004-03-17 |
2015-01-21 |
Revivicor, Inc. |
Tissue products derived from animals lacking any expression of functional alpha 1,3 galactosyltransferase
|
|
NZ550106A
(en)
*
|
2004-04-22 |
2009-06-26 |
Kyowa Hakko Kirin Co Ltd |
Transgenic animals and uses thereof
|
|
US20060053500A1
(en)
*
|
2004-05-28 |
2006-03-09 |
Univ. of Pittsburgh of the Commonwealth System of Higher Education, Office of Technology Management |
Modification of sugar metabolic processes in transgenic cells, tissues and animals
|
|
US20060147429A1
(en)
*
|
2004-12-30 |
2006-07-06 |
Paul Diamond |
Facilitated cellular reconstitution of organs and tissues
|
|
US20060148080A1
(en)
*
|
2004-12-30 |
2006-07-06 |
Paul Diamond |
Methods for supporting and producing human cells and tissues in non-human mammal hosts
|
|
US8828433B2
(en)
|
2005-04-19 |
2014-09-09 |
Advanced Cardiovascular Systems, Inc. |
Hydrogel bioscaffoldings and biomedical device coatings
|
|
US8303972B2
(en)
|
2005-04-19 |
2012-11-06 |
Advanced Cardiovascular Systems, Inc. |
Hydrogel bioscaffoldings and biomedical device coatings
|
|
US9539410B2
(en)
|
2005-04-19 |
2017-01-10 |
Abbott Cardiovascular Systems Inc. |
Methods and compositions for treating post-cardial infarction damage
|
|
US8187621B2
(en)
|
2005-04-19 |
2012-05-29 |
Advanced Cardiovascular Systems, Inc. |
Methods and compositions for treating post-myocardial infarction damage
|
|
US20080125745A1
(en)
|
2005-04-19 |
2008-05-29 |
Shubhayu Basu |
Methods and compositions for treating post-cardial infarction damage
|
|
US7732190B2
(en)
|
2006-07-31 |
2010-06-08 |
Advanced Cardiovascular Systems, Inc. |
Modified two-component gelation systems, methods of use and methods of manufacture
|
|
US9242005B1
(en)
|
2006-08-21 |
2016-01-26 |
Abbott Cardiovascular Systems Inc. |
Pro-healing agent formulation compositions, methods and treatments
|
|
US9005672B2
(en)
|
2006-11-17 |
2015-04-14 |
Abbott Cardiovascular Systems Inc. |
Methods of modifying myocardial infarction expansion
|
|
US8741326B2
(en)
|
2006-11-17 |
2014-06-03 |
Abbott Cardiovascular Systems Inc. |
Modified two-component gelation systems, methods of use and methods of manufacture
|
|
US8192760B2
(en)
|
2006-12-04 |
2012-06-05 |
Abbott Cardiovascular Systems Inc. |
Methods and compositions for treating tissue using silk proteins
|
|
KR101149475B1
(ko)
|
2007-11-30 |
2012-05-25 |
한국생명공학연구원 |
이종 장기 이식용 미니 복제돼지 생산을 위한 유전자 조작된 세포주 및 그의 생산방법
|
|
KR101178946B1
(ko)
|
2008-02-01 |
2012-09-03 |
한국생명공학연구원 |
알파 1,3-갈락토실트랜스퍼라아제 유전자 타겟팅 벡터
|
|
KR101068479B1
(ko)
|
2008-07-30 |
2011-09-29 |
한국생명공학연구원 |
알파 1,3-갈락토실트랜스퍼라아제 유전자 타겟팅 벡터 및그의 용도
|
|
KR20120050485A
(ko)
|
2009-08-14 |
2012-05-18 |
레비비코르 인코포레이션 |
당뇨병 치료를 위한 복수 형질전환 돼지
|
|
WO2012112586A1
(en)
|
2011-02-14 |
2012-08-23 |
Revivicor, Inc. |
Genetically modified pigs for xenotransplantation of vascularized xenografts and derivatives thereof
|
|
WO2013169929A1
(en)
|
2012-05-08 |
2013-11-14 |
The General Hospital Corporation |
Reducing immunogenicity of xenogeneic transplant tissues
|
|
US9980471B2
(en)
|
2012-06-12 |
2018-05-29 |
The General Hospital Corporation |
Miniature swine transgenic for one or more coagulation factors
|
|
WO2015066668A1
(en)
|
2013-11-04 |
2015-05-07 |
Lifecell Corporation |
Methods of removing alpha-galactose
|
|
WO2018195402A1
(en)
|
2017-04-20 |
2018-10-25 |
Egenesis, Inc. |
Methods for generating genetically modified animals
|
|
US10883084B2
(en)
|
2018-10-05 |
2021-01-05 |
Xenotherapeutics, Inc. |
Personalized cells, tissues, and organs for transplantation from a humanized, bespoke, designated-pathogen free, (non-human) donor and methods and products relating to same
|
|
US10799614B2
(en)
|
2018-10-05 |
2020-10-13 |
Xenotherapeutics, Inc. |
Xenotransplantation products and methods
|
|
IL302983A
(en)
|
2020-11-20 |
2023-07-01 |
Revivicor Inc |
Multitransgenic pigs with growth hormone receptor silencing for xenotransplantation
|